Monday, 23 July 2018

India Diabetes Market, Segments, Growth and Value Chain 2018

Market Scenario:
Diabetes is a chronic metabolic disease that cause high blood sugar due to which body becomes incapable of producing insulin. According to World Health Organization (WHO), India had 69.2 million people living with diabetes (8.7%) in 2015. About 90% of the patients are suffering from Type 2 diabetes. Increasing awareness, increasing number of patients, untouched rural market, increasing urbanization, developing healthcare infrastructure and increasing spending on healthcare are driving the market for diabetes in India. India Diabetes Market is expected to grow at the average CAGR of 6.5% during 2016-2023. India Diabetes Market is growing rapidly. India Diabetes Market is expected to grow US$ 7441.6 million by 2023 from US$ 4778.7 million in 2016.
Intended Audience
Hospitals and Clinics
Diabetes drugs and devices manufacturers
Diabetes drugs and devices suppliers
Government and Independent Regulatory Authorities
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Medical Research Laboratories
Potential Investors
Segments:                                                                                                                                        
India Diabetes Market has been segmented on the basis of type which comprise Type 1, Type 2, and Gestational diabetes. On the basis of test market is segmented into Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance test, Initial glucose challenge test and others. On the basis of devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others. On the basis of treatment, market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and others.
Regional Analysis of India Diabetes Market:                  
Considering the scenario of the Indian diabetes market, western region is believed to be the largest market for diabetes. Moreover the Eastern and Northern regions are also growing and second largest market for India Diabetes. On the other hand, Southern Indian market is expected to grow at significant rate in the India diabetes during the forecasted period. Central region is likely to have a limited but moderate growth in the market.

Key Players for India Diabetes Market:                                                         
Some of the key players in this market are: Novo Nordisk A/S (Denmark), USV Private Limited (India), sanofi-aventis U.S. LLC (US), Novartis AG (Switzerland), Merck & Co., Inc. (US), Becton Dickinson and Company (US), Roche Diabetes Care, Inc.(US),Johnson & Johnson Services, Inc.(us), Bayer AG (Germany), Ypsomed (Switzerland)

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2966
List of Tables and Figures:
List Of Tables
Table 1 India Diabetes Market By Type
Table 2 India Diabetes Market By Test
Table 3 India Diabetes Market By Devices
Table 4 India Diabetes Market By Treatment
Table 5 India Diabetes Market By Region
List Of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 India Diabetes Market By Type
Figure 4 India Diabetes Market By Test
Figure 5 India Diabetes Market By Devices
Figure 5 India Diabetes Market By Treatment
Figure 7 India Diabetes Market By Region
Figure 8 India Diabetes Market By Region: Company Share Analysis, 2015 (%)

...Continued

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

No comments:

Post a Comment